Cited by 625Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index.

Tau phosphorylation in neuronal cell function and dysfunction

Johnson, Gail V. W., Stoothoff, William H.·2004·Journal of Cell Science

DOI 10.1242/jcs.01558

Open this paper in CoChat — free account

Abstract

Tau is a group of neuronal microtubule-associated proteins that are formed by alternative mRNA splicing and accumulate in neurofibrillary tangles in Alzheimer's disease (AD) brain. Tau plays a key role in regulating microtubule dynamics, axonal transport and neurite outgrowth, and all these functions of tau are modulated by site-specific phosphorylation. There is significant evidence that a disruption of normal phosphorylation events results in tau dysfunction in neurodegenerative diseases, such as AD, and is a contributing factor to the pathogenic processes. Indeed, the abnormal tau phosphorylation that occurs in neurodegenerative conditions not only results in a toxic loss of function (e.g. decreased microtubule binding) but probably also a toxic gain of function (e.g. increased tau-tau interactions). Although tau is phosphorylated in vitro by numerous protein kinases, how many of these actually phosphorylate tau in vivo is unclear. Identification of the protein kinases that phosphorylate tau in vivo in both physiological and pathological processes could provide potential therapeutic targets for the treatment of AD and other neurodegenerative diseases in which there is tau pathology.

Integrity signals

Registry

Crossref · 10.1242/jcs.01558

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Neurodegenerative Tauopathies
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Patrick, G. N., Zukerberg, L. R., Nikolić, M., de la Monte, S. M., Dikkes, P., & Tsai, L. (1999) · Nature · doi:10.1038/45159 · Cited by 1,541
The glamour and gloom of glycogen synthase kinase-3
Jope, R. S., & Johnson, G. V. W. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.004 · Cited by 1,535
Self-citation

Flagged first, then by citations

Show all 122 references

1 of the 122 references couldn’t be matched to a known paper.

Sorted by citations

Items 401–500 of 625

Functional Interactions of Tau Phosphorylation Sites That Mediate Toxicity and Deficient Learning in Drosophila melanogaster
Keramidis, I., Vourkou, E., Papanikolopoulou, K., & Skoulakis, E. M. C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.569520 · Cited by 11
A novel structure associated with aging is augmented in the DPP6-KO mouse brain
Lin, L., Petralia, R. S., Lake, R. G., Wang, Y., & Hoffman, D. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01065-7 · Cited by 11
Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease
Martínez-Drudis, L., Sheta, R., Pellegrinato, R., Loukili, S., Tremblay, C., Calon, F., Rivest, S., & Oueslati, A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105833 · Cited by 12
Biochemical Characterization of Epigallocatechin-3-gallate as an Effective Stimulator for the Phosphorylation of Its Binding Proteins by Glycogen Synthase Kinase-3β in Vitro
Miyai, S., Yamaguchi, A., Iwasaki, T., Shamsa, F., & Ohtsuki, K. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1932 · Cited by 11
REMOVED: Nanodelivery of oxiracetam enhances memory, functional recovery and induces neuroprotection following concussive head injury
Niu, F., Sharma, A., Wang, Z., Feng, L., Muresanu, D. F., Sahib, S., Tian, Z. R., Lafuente, J. V., Buzoianu, A. D., Nozari, A., et al. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.06.004 · Cited by 10
Sustained Microglial Activation Promotes Synaptic Loss and Neuronal Dysfunction after Recovery from ZIKV Infection
Kim, N., Choi, H., Kim, U., Kim, S., Kim, Y. B., & Shin, H. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179451 · Cited by 10
MAD—microbial (origin of) Alzheimer’s disease hypothesis: from infection and the antimicrobial response to disruption of key copper-based systems
Min, J.-H., Sarlus, H., & Harris, R. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1467333 · Cited by 11
Prolyl isomerase Pin1 promotes proplatelet formation of megakaryocytes via tau
Shimizu, T., Uchida, C., Shimizu, R., Motohashi, H., & Uchida, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.115 · Cited by 10
Activation of TRPV4 induces intraneuronal tau hyperphosphorylation via cholesterol accumulation
Du, K., Dou, Y., Chen, K., & Zhao, Y. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114392 · Cited by 10
Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling
Shah, S. J. A., Zhang, Q., Guo, J., Liu, H., Liu, H., & Villà-Freixa, J. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00578 · Cited by 10
Association of the herpes simplex virus major tegument structural protein VP22 with chromatin
Ingvarsdottir, K., & Blaho, J. A. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.08.002 · Cited by 10
O papel das proteínas do citoesqueleto na fisiologia celular normal e em condições patológicas
Monteiro, M. R., Kandratavicius, L., & Leite, J. P. (2011) · Journal of Epilepsy and Clinical Neurophysiology · doi:10.1590/s1676-26492011000100005 · Cited by 10
The Involvement of NR2B and tau Protein in MG132-Induced CREB Dephosphorylation
Xie, M., Li, Y., Wang, S., Yu, Q., Meng, X., & Liao, X. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0919-8 · Cited by 10
The small molecular CCR3 antagonist YM344031 attenuates neurodegenerative pathologies and improves learning and memory performance in a mouse model of Alzheimer’s disease
Sui, Y., Zhang, Y., Dong, C., Xu, B., & Sun, X. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.022 · Cited by 11
A New Strategy for Preventive and Functional Therapeutic Methods for Dementia —Approach Using Natural Products—
Ohizumi, Y. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.14-00245 · Cited by 11
Proteomic Analysis of Adult Human Hippocampal Subfields Demonstrates Regional Heterogeneity in the Protein Expression
Mol, P., Gopalakrishnan, L., Chatterjee, O., Mangalaparthi, K. K., Kumar, M., Durgad, S. S., Nair, B. G., Shankar, S. K., Mahadevan, A., & Prasad, T. S. K. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00143 · Cited by 8
Cholesterol profiling reveals 7β‐hydroxycholesterol as a pathologically relevant peripheral biomarker of Alzheimer's disease
Ha, J., Kwon, G. E., Son, Y., Jang, S. A., Cho, S. Y., Park, S. J., Kim, H. J., Lee, J., Lee, J., Seo, D., et al. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13706 · Cited by 9
A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer’s Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants
Tsamou, M., Pistollato, F., & Roggen, E. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201418 · Cited by 9
Resistance wheel exercise from mid-life has minimal effect on sciatic nerves from old mice in which sarcopenia was prevented
Krishnan, V. S., White, Z. R., Terrill, J. R., Hodgetts, S. I., Fitzgerald, M., Shavlakadze, T., Harvey, A. R., & Grounds, M. D. (2017) · Biogerontology · doi:10.1007/s10522-017-9714-8 · Cited by 9
Nanoparticulates
Hubbs, A. F., Porter, D. W., Mercer, R. R., Castranova, V., Sargent, L. M., & Sriram, K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415759-0.00043-1 · Cited by 9
Pathophysiology Associated with Diabetes-induced Tauopathy and Development of Alzheimer’s Disease
Sur, D., Sarkar, P., Banu, S., Bhattacharya, S., & Bala, A. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220513142030 · Cited by 9
Big versus small: The impact of aggregate size in disease
Hnath, B., Chen, J., Reynolds, J., Choi, E. S., Wang, J., Zhang, D., Sha, C. M., & Dokholyan, N. V. (2023) · Protein Science · doi:10.1002/pro.4686 · Cited by 8
Inositol 1,4,5-Trisphosphate 3-Kinase A Is a Novel Microtubule-associated Protein
Lee, D., Lee, H. W., Hong, S., Choi, B.-I., Kim, H., Han, S. B., Kim, I. H., Bae, Y. C., Bae, Y. C., Rhyu, I. J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.344101 · Cited by 9
In Vitro Biochemical Assays for O‐GlcNAc‐Processing Enzymes
Kim, E. J. (2017) · ChemBioChem · doi:10.1002/cbic.201700138 · Cited by 9
Novel molecular mechanisms in Alzheimer’s disease: The potential role of DEK in disease pathogenesis
Greene, A. N., Solomon, M. B., & Vinnedge, L. M. P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1018180 · Cited by 8
Acquisition of cell polarity during cell cycle and oral replacement in Tetrahymena
Kaczanowska, J., Kaczanowski, S., Kiersnowska, M., Fabczak, H., Tułodziecka, K., & Kaczanowski, A. (2008) · The International Journal of Developmental Biology · doi:10.1387/ijdb.072350jk · Cited by 8
Tau haploinsufficiency causes prenatal loss of dopaminergic neurons in the ventral tegmental area and reduction of transcription factor orthodenticle homeobox 2 expression
Zheng, M., Jiao, L., Tang, X., Xiang, X., Wan, X., Yan, Y., Li, X., Zhang, G., Li, Y., Jiang, B., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201601303r · Cited by 8
The puzzle of preserved cognition in the oldest old
Bugiani, O. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04111-y · Cited by 8
Astrocytes and Inflammatory Processes in Alzheimer’s Disease
Vallés, S. L., Burguet, F., Iradi, A., Aldasoro, M., Vila, J. M., Aldasoro, C., & Jorda, A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88701 · Cited by 9
Non-invasive in vivo imaging of brain and retinal microglia in neurodegenerative diseases
Etebar, F., Harkin, D. G., White, A. R., & Dando, S. J. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1355557 · Cited by 7
STAU1 exhibits a dual function by promoting amyloidogenesis and tau phosphorylation in cultured cells
Li, C., Zhou, G., Xie, X., Wang, L., Chen, X., Pan, Q., Pu, Y., Yang, J., Li, S., & Chen, G. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114805 · Cited by 9
Comparison of Serum Neurofilament Light Chain and Tau Protein Levels in Cases with Autism Spectrum Disorder and Their Healthy Siblings and Healthy Controls
Öz, F., Kaya, İ., Tanır, Y., Küçükgergin, C., & Aydin, A. F. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.23.1153 · Cited by 7
Strategizing the Development of Alzheimer’s Therapeutics
Davis, J. B., & Couch, R. D. (2014) · Advances in Alzheimer s Disease · doi:10.4236/aad.2014.33011 · Cited by 7
The Role of p53 in Alzheimer’s Disease: Impact on Tau Pathology
Jembrek, M. J., Newberg, K., & Šimić, G. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_4 · Cited by 7
Zeaxanthin Attenuates the Vicious Circle Between Endoplasmic Reticulum Stress and Tau Phosphorylation: Involvement of GSK-3β Activation
Zhang, L.-N., Li, M.-J., Shang, Y.-H., Liu, Y.-R., Han-Chang, H., & Lao, F.-X. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215408 · Cited by 8
Development of a Cellular Tau Enzyme-Linked Immunosorbent Assay Method for Screening GSK-3β Inhibitors
Cho, G., Noh, M., Kang, B. Y., Ku, I.-W., Park, J., Hong, Y., Kim, M., & Kim, S. H. (2011) · Assay and Drug Development Technologies · doi:10.1089/adt.2010.0343 · Cited by 7
UCH-L1 Inhibition Involved in CREB Dephosphorylation in Hippocampal Slices
Xie, M., Wang, S., Lu, Z., Pan, Y., Chen, Q.-C., & Liao, X. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0197-z · Cited by 7
Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer's disease
Maltsev, A. V., Dovidchenko, N. V., Uteshev, V. K., Sokolik, V. V., Shtang, O. M., Yakushin, M. A., Sokolova, N. M., Surin, A. K., & Galzitskaya, O. V. (2013) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20135902144 · Cited by 7
Lamotrigine attenuates cerebral ischemia-induced cognitive impairment and decreases β-amyloid and phosphorylated tau in the hippocampus in rats
Han, H., Qian, Q., Yu, Y., Zhao, D., & Sun, G. (2015) · Neuroreport · doi:10.1097/wnr.0000000000000424 · Cited by 7
Misfolded proteins as a therapeutic target in Alzheimer's disease
Liyanage, S. I., & Weaver, D. F. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.08.003 · Cited by 8
Tau knockout exacerbates degeneration of parvalbumin‐positive neurons in substantia nigra pars reticulata in Parkinson's disease‐related α‐synuclein A53T mice
Jiao, L., Zheng, M., Duan, J., Wu, T., Li, Z., Liu, L., Xiang, X., Tang, X., He, J., Li, X., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000017rr · Cited by 7
Age dependent trans-cellular propagation of human tau aggregates in Drosophila disease models
Aqsa, A., & Sarkar, S. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147207 · Cited by 7
Phosphorylation-Dephosphorylation Imbalance of Cytoskeletal Associated Proteins in Neurodegenerative Diseases
Benítez‐King, G., Ortíz‐López, L., Morales‐Mulia, S., Jiménez-Rubio, G., Ramírez-Rodríguez, G. B., & Meza, I. (2006) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488906777452776 · Cited by 7
The induction of tau aggregation is restricted by sulfamethoxazole and provides new information regarding the use of the drug
Akbari, V., Bahramikia, S., Jalalvand, A. R., Mehrabi, M., Ezati, M., & Khodarahmi‬, R. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2273433 · Cited by 6
Zebrafish Experimental Animal Models for AD: A Comprehensive Review
Sande, R., Godad, A. P., & Doshi, G. (2024) · Current Clinical Pharmacology · doi:10.2174/0127724328279684240104094257 · Cited by 6
Morphological classification and changes in dementia (Review)
Tudor, A., Vasile, A., Trifu, S. C., & Cristea, M. B. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10955 · Cited by 7
Quantitative Structure‐Activity Relationship Analysis and a Combined Ligand‐Based/Structure‐Based Virtual Screening Study for Glycogen Synthase Kinase‐3
Fu, G., Liu, S., Nan, X., Dale, O. R., Zhao, Z., Chen, Y., Wilkins, D. E., Manly, S. P., Cutler, S. J., & Doerksen, R. J. (2014) · Molecular Informatics · doi:10.1002/minf.201400045 · Cited by 6
Insight into Atomic Resolution of the Cross‐Seeding between Tau/Mutated Tau and Amyloid‐β in Neurodegenerative Diseases
Atsmon‐Raz, Y., & Miller, Y. (2015) · Israel Journal of Chemistry · doi:10.1002/ijch.201400162 · Cited by 6
JNK-interacting protein 1 mediates Alzheimer's-like pathological features in AICD-transgenic mice
Margevicius, D., Bastian, C., Fan, Q., Davis, R. J., & Pimplikar, S. W. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.013 · Cited by 7
Potential Link Between Proprotein Convertase Subtilisin/Kexin Type 9 and Alzheimer’s Disease
Oldham, C. E., & Lopez, D. (2018) · International Journal of Biomedical Investigation · doi:10.31531/2581-4745.1000106 · Cited by 5
PTEN inhibition induces neuronal differentiation and neuritogenesis in SH-SY5Y cells via AKT signaling pathway
Moreira, N. C. D. S., Piassi, L. D. O., Lima, J. E. B. D. F., Passos, G. A. S., & Sakamoto‐Hojo, E. T. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251352194 · Cited by 5
The Mitochondrial Guardian α‐Amyrin Mitigates Alzheimer's Disease Pathology via Modulation of the DLK‐SARM1‐ULK1 Axis
Cao, S., Jiménez‐Loygorri, J. I., Qiu, Y., Kang, Y. J., Do, K. V., Smith, A. E., Huang, J., Pan, J., Mao, L., Li, A., et al. (2026) · Advanced Science · doi:10.1002/advs.202512374 · Cited by 6
ISX-9 Promotes KGF Secretion From MSCs to Alleviate ALI Through NGFR-ERK-TAU- β -Catenin Signaling Axis
Tian, Y., Deng, Q., Yang, X., Wang, C., Le, V. M., Ji, R., Liang, X., & Feng, Y. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad085 · Cited by 5
Targeted brain-specific tauopathy compromises peripheral skeletal muscle integrity and function
Alava, B. R., Hery, G. P., Sidhom, S., Gutierrez‐Monreal, M. A., Prokop, S., Esser, K. A., & Abisambra, J. F. (2024) · Aging Brain · doi:10.1016/j.nbas.2024.100110 · Cited by 5
Effects of compensation, connectivity and tau in a computational model of Alzheimer's Disease
Rowan, M. (2011) · International Joint Conference on Neural Networks (IJCNN) · doi:10.1109/ijcnn.2011.6033268 · Cited by 5
Total-tau and Phospho-tau(181Thr) in Cerebrospinal Fluid of Neurologically Intact Population Increase with Age
Jaworski, J., Psujek, M., & Bartosik-Psujek, H. (2009) · Folia Biologica · doi:10.14712/fb2009055040126 · Cited by 5
Neuropathology of Traumatic Brain Injury and Its Role in the Development of Alzheimer’s Disease
Villapol, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81945 · Cited by 5
Tau Abnormalities and Autophagic Defects in Neurodegenerative Disorders; A Feed-forward Cycle
Samimi, N., Asada, A., & Ando, K. (2020) · Galen Medical Journal · doi:10.31661/gmj.v9i0.1681 · Cited by 5
Selective inhibition of phosphodiesterase 4D increases tau phosphorylation at Ser214 residue
Villa, V., Montalto, G., Caudano, F., Fedele, E., & Ricciarelli, R. (2022) · BioFactors · doi:10.1002/biof.1847 · Cited by 5
Natural product-based bioactive agents in combination attenuate neuroinflammation in a tri-culture model
Liu, Y., Chang, D., Liu, T., & Zhou, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1135934 · Cited by 4
The γ-Adducin 1–357 fragment promotes tau pathology
Yu, H., Xiong, M., Liu, C., Xia, D., Meng, L., & Zhang, Z. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1241750 · Cited by 5
Emerging Therapeutic Strategies in Alzheimer's Disease
Chiba, T. (2013) · InTech eBooks · doi:10.5772/55293 · Cited by 5
Modulating the phosphorylation status of target proteins through bifunctional molecules
He, Q., Wang, Z., Wang, R., Lu, T., Chen, Y., & Lü, S. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104307 · Cited by 4
Endothelin‐1‐induced down‐regulation of Na V 1.7 expression in adrenal chromaffin cells: Attenuation of catecholamine secretion and tau dephosphorylation
Nemoto, T., Yanagita, T., Maruta, T., Sugita, C., Satoh, S., Kanai, T., Wada, A., & Murakami, M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.02.013 · Cited by 4
Alzheimer’s Disease Therapy: Present and Future Molecules
Kumar, A., & Kumar, A. (2017) · Neuromethods · doi:10.1007/978-1-4939-7404-7_1 · Cited by 4
Prolyl Isomerase Pin1 Directly Regulates Calcium/Calmodulin-Dependent Protein Kinase II Activity in Mouse Brains
Shimizu, T., Kanai, K., Sugawara, Y., Uchida, C., & Uchida, T. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01351 · Cited by 4
Docking studies of Tau Protein
Singh, H., Marla, S. S., & Agarwal, M. (2006) · International MultiConference of Engineers and Computer Scientists · Cited by 4
Molecular Aspects of Memory Dysfunction in Alzheimer’s Disease
Chin, J., Roberson, E. D., & Mucke, L. (2008) · Elsevier eBooks · doi:10.1016/b978-012370509-9.00015-2 · Cited by 5
Pathological Assessment of Chronic Traumatic Encephalopathy
Ommeren, R. V., & Hazrati, L. (2018) · Academic Forensic Pathology · doi:10.1177/1925362118797729 · Cited by 4
Quantitative endophenotypes as an alternative approach to understanding genetic risk in neurodegenerative diseases
Farias, F., Benítez, B. A., & Cruchaga, C. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105247 · Cited by 4
Long-term gabapentin treatment impairs cognitive function in aged mice via tau hyperphosphorylation
Xia, S., You, Z., Wu, X., Yang, J., Wang, S., Li, N., Dai, J., Dong, Y., Chen, L. L., Yan, M., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1616775 · Cited by 3
Is tau pathology a relevant factor in neuronal damage induced by alcohol and other drugs?
Olesen, M. A., Ancía, A., & Quintanilla, R. A. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168059 · Cited by 3
Flavonoid-Based Derivatives for Modulating Various Targets of Alzheimer’s Disease
Pandey, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_11 · Cited by 3
Planarian microtubules form a network within muscle and regulate injury-induced genes essential for regeneration patterning
Anderson, X., & Petersen, C. P. (2025) · Development · doi:10.1242/dev.204669 · Cited by 3
Glucose Starvation Causes ptauS409 Increase in N2a Cells Through ATF3/PKAcα Signaling Pathway
Zuo, Z., Li, L., Yan, X., & Zhang, L. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03686-x · Cited by 3
Abnormal Hyperphosphorylation of Tau in Canine Immune-mediated Meningoencephalitis
Son, M., Chae, Y., Kim, S., Yun, T., Koo, Y., Lee, D., Kim, H., Yang, M., Kang, B., & Kim, S. (2023) · In Vivo · doi:10.21873/invivo.13181 · Cited by 3
The interplay between Wnt signaling pathways and microtubule dynamics
Kikuchi, K., & Arata, M. (2024) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-024-00860-z · Cited by 3
Research Progress in Alzheimer’s Disease
张, 苹. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1472138 · Cited by 3
Blood biomarkers to identify patients with different intracranial lesion combinations after traumatic brain injury
Koivikko, P., Katila, A. J., Takala, R. S. K., Hossain, I., Luoto, T. M., Raj, R., Koivisto, M. A., Tenovuo, O. S., Blennow, K., Hutchinson, P. J., et al. (2025) · Brain and Spine · doi:10.1016/j.bas.2025.104195 · Cited by 3
The Insight into the Role of Protein Misfolding and Tau Oligomers in Alzheimer’s Disease
Pandey, P., Kumar, C., & Khandia, R. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_12 · Cited by 3
Elevated 24-hydroxycholesterol levels counteract okadaic acid-induced tau hyperphosphorylation and neuronal morphology impairment
Giannelli, S. G., Eroli, F., Loera‐Valencia, R., Leoni, V., Latorre‐Leal, M., Testa, G., Staurenghi, E., Sottero, B., Gamba, P., Maioli, S., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107029 · Cited by 3
Phosphorylation at serine 214 correlates with tau seeding activity in an age-dependent manner in two mouse models for tauopathies and is required for tau transsynaptic propagation
Martínez, P., Jury, N., Patel, H., You, Y., Perkins, A., You, Y., Lee‐Gosselin, A., Vidal, R., & Lasagna‐Reeves, C. A. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251372603 · Cited by 3
Immature Persimmon Suppresses Amyloid Beta (Aβ) Mediated Cognitive Dysfunction via Tau Pathology in ICR Mice
Yoo, S. K., Kim, J. M., Lee, U., Kang, J.-Y., Park, S.-K., Han, H.-J., Park, H.-W., Kim, H., Kim, C. W., Kim, M.-J., et al. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43010033 · Cited by 3
Tau and Amyloid- Conformational Change to -Sheet Structures as Effectors in the Development of Alzheimer's Disease
Anda-Hernández, M. A. D., León, K. I. L.-D., Mena, R., Campos‐Peña, V., & Meraz‐Ríos, M. A. (2012) · InTech eBooks · doi:10.5772/37909 · Cited by 3
Screening Dyrk1A inhibitors by MALDI-QqQ mass spectrometry: systematic comparison to established radiometric, luminescence, and LC–UV–MS assays
Gode, D., Schmitt, C., Engel, M., & Volmer, D. A. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7703-1 · Cited by 3
Tau hyperphosphorylation and axonal damage induced by N,N‐diethyldithiocarbamate (DEDTC) treatment along late postnatal development is followed by a rescue during adulthood
Utrera, J., Junyent, F., de Lemos, L., Pallàs, M., Camins, A., Romero, R., & Auladell, C. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22284 · Cited by 3
Syndromes parkinsoniens et sclérose latérale amyotrophique
Forestier, N. L., Lacomblez, L., & Meininger, V. (2008) · Revue Neurologique · doi:10.1016/j.neurol.2008.02.043 · Cited by 3
AMYLOID-TARGETED IN ALZHEIMER'S DISEASE: USE OF HUMAN ALBUMIN IN PLASMA EXCHANGE AS A NOVEL APPROACH FOR Aβ
Boada, M., Ortiz, P., Hernández, I., Muñoz, J., Núñez, L., Olazarán, J., Cuberas‐Borrós, G., & Tárraga, L. (2009) · Cited by 3
Cytoskeletal disruption as a biomarker of developmental neurotoxicity
Hargreaves, A. J., Sachana, M., & Flaskos, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404630-6.00050-6 · Cited by 3
Human chorionic gonadotropin decreases the phosphorylated tau protein level in streptozotocin-Alzheimeric male rats’ hippocampus
Bahlakeh, G., Jahanshahi, M., & Saeidi, M. (2018) · Folia Neuropathologica · doi:10.5114/fn.2018.76619 · Cited by 3
Neurodegenerative Disorders
Nagaratnam, N., Nagaratnam, K., & Cheuk, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-32700-6_71-1 · Cited by 3
Identification, biological evaluation, and crystallographic analysis of coumestrol as a novel dual-specificity tyrosine-phosphorylation-regulated kinase 1A inhibitor
Peng, C.-H., Hwang, T., Hung, S.-C., Tu, H., Tseng, Y.-T., Lin, T. E., Lee, C., Tseng, Y.-C., Ko, C., Yen, S., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136860 · Cited by 3
Investigating the ameliorative effect of Kalanchoe pinnata on neuroinflammation-associated Alzheimer’s disease using network pharmacology, molecular docking, and in vitro studies
Khandayataray, P., & Murthy, M. K. (2025) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-025-00688-z · Cited by 2
Chronic Fatty Acid Exposure Disrupts SH-SY5Y and Neuronal Differentiation and Is a Potential Link Between Type-2 Diabetes and Alzheimer’s Disease
Targett, I. L., Pring, K., Valiente, A. I. M., Qualtrough, D., Conway, M. E., Crompton, L., & Craig, T. J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05367-6 · Cited by 2
Blood neurodegeneration biomarkers and the muscle–brain axis in older adults: physical performance as a functional mediator of cognition
Ceolin, C., Noale, M., Musso, G., Sturani, S., Ravelli, A., Simonato, C., Busetto, L., Antonini, A., Fiorenzato, E., Montagnana, M., et al. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113123 · Cited by 2
Protein kinases as therapeutic targets in Alzheimer’s disease: challenges, insights, and new frontiers
Tak, C., Bhujbal, S. P., & Hah, J. (2026) · Medicinal Chemistry Research · doi:10.1007/s00044-026-03557-y · Cited by 2
AAV8-P301L tau expression confers age-related disruptions in sleep quantity and timing
Alava, B. R., Morris, A. R., Liu, A. C., Abisambra, J. F., & Esser, K. A. (2024) · npj Biological Timing and Sleep · doi:10.1038/s44323-024-00009-x · Cited by 2
Overview and Applications of Nanocarrier-Based Drug Delivery for Alleviating Alzheimer’s Disease
Khan, S. A., Haider, M. F., & Naseem, N. (2025) · Journal of Bio-X Research · doi:10.34133/jbioxresearch.0042 · Cited by 2
Poneratoxin as a key tool for investigating the relationship between sodium channel hypersensitivity and impaired nerve cell function
Lü, Z., Dai, X., Xu, J., Zhu, M., Chen, B., Guo, Y., Gao, Z., & Meng, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-11459-z · Cited by 2
Molecular Markers of Early Diagnosis of Alzheimer Disease: Prospects for Research in Peripheral Tissues
Paltseva, E. M., Zuev, V. A., Kozhevnikova, E. O., Linkova, N. S., Kvetnaia, T. V., Polyakova, V. O., & Kvetnoy, I. M. (2018) · Advances in Gerontology · doi:10.1134/s2079057018020133 · Cited by 2

Authors: Johnson, G. V. W., & Stoothoff, W. H.
Affiliations: University of Alabama at Birmingham (US)
ORCID: Johnson, Gail V. W.
Venue: Journal of Cell Science
Publisher: The Company of Biologists
Published: 2004-11-15
Volume: 117
Issue: 24
Pages: 5721-5729
ISSN: 0021-9533 (ISSN-L)
1477-9137
DOI: 10.1242/jcs.01558
OpenAlex: W2118867129
Cited by: 624
References: 122
Citations by year: 2026: 10 · 2025: 25 · 2024: 27 · 2023: 53 · 2022: 36 · 2021: 38 · 2020: 47 · 2019: 33 · 2018: 41 · 2017: 31 · 2016: 32 · 2015: 19 · 2014: 32 · 2013: 29 · 2012: 29
FWCI: 1.32
Type: journal article
Language: en
Open access: closed
Locations: Journal of Cell Science (publishedVersion)
PubMed (publishedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: tau phosphorylation, tau protein, Alzheimer's disease, neurofibrillary tangles, microtubule dynamics, axonal transport, neurite outgrowth, protein kinases, neurodegenerative diseases, therapeutic target
MeSH terms: Alzheimer Disease, Animals, Axons, Axonal Transport, Brain, Humans, Microtubules, Models, Biological, Neurons, Phosphorylation, RNA, Messenger, Neurofibrillary Tangles, tau Proteins, Alternative Splicing, Protein Structure, Tertiary, Neurodegenerative Diseases, Protein Isoforms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tau phosphorylation in neuronal cell function and dysfunction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks